Acción 000590 TUS-PHARMACEUTICAL GROUP CO., LTD.
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas Tus-Pharmaceutical Group Co., Ltd.

Acciones

000590

CNE000000701

Precio de cierre Shenzhen S.E.
Otros sitios de cotización
 00:00:00 11/06/2024 		Varia. Cinco días. Varia. 1 de enero.
5,62 CNY -1,40 % Gráfico intradía de Tus-Pharmaceutical Group Co., Ltd. -5,39 % -37,28 %
25/04 Tus-Pharmaceutical Group Co. informa de los resultados del primer trimestre finalizado el 31 de marzo de 2024 CI
27/03 Tus-Pharmaceutical Group Co. presenta los resultados del ejercicio cerrado el 31 de diciembre de 2023 CI

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
Tus-Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Tus-Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Tus Pharmaceutical to Boost Investment in Chemical Park Project
Tus-Pharmaceutical Group Co., Ltd. agreed to acquire 55% stake in Wuhan Medtek Pharmaceutical Co., Ltd. from Tan Yunliang and Wang Zhong for approximately CNY 140 million.
Tus-Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Tus-Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Tus-Pharmaceutical Group Co., Ltd. Approves Board Appointments
Tus Pharmaceutical to Set Up New Marketing Subsidiary
Tus-Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Guhan Traditional Chinese Medicine Co., Ltd. announced that it expects to receive CNY 22 million in funding from Tus-Pharmaceutical Group Co., Ltd.
Tus-Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
Tus-Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
Tus-Pharmaceutical Group Co., Ltd. completed the acquisition of Guangdong Sinotau Pharmaceutical Co., Ltd. from Beijing Xiantongyuan Pharmaceutical Technology Co., Ltd. and Li Yinqiang.
Tus Pharmaceutical to Buy Local Drugmaker Xiantong for $33 Million
Tus-Pharmaceutical Group Co., Ltd. agreed to acquire 100% stake in Guangdong Sinotau Pharmaceutical Co., Ltd. from Beijing Xiantongyuan Pharmaceutical Technology Co., Ltd. and Li Yinqiang fron CNY220 million.
Tus-Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
Tus-Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
Hunan Tus-Pharmaceutical Biological Co., Ltd. announced that it expects to receive CNY 25 million in funding from Tus-Pharmaceutical Group Co., Ltd., Ningbo Yiduoduo Electronic Commerce Co., Ltd.
Tus-Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021
Tus-Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción 000590
  4. Noticias Tus-Pharmaceutical Group Co., Ltd.
  5. Otros idiomas